-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Responsible Editor: Food Science
Gastric cancer is a common malignant tumor
FIP-nha is a new type of FIP first discovered in the ascomycete Nectria haematococca by gene mining
The results show that FIP-nha can significantly inhibit the proliferation of AGS and SGC7901 in a time- and concentration-dependent manner, but has almost no toxic effect on normal cells; FIP-nha can both promote apoptosis and autophagy in two gastric cancer cells; in-depth Mechanism exploration confirmed that FIP-nha competes with EGF to bind EGFR, thereby reducing the activation effect of EGF on EGFR and its downstream signaling molecules STAT3 and Akt; The cell surface structure of the transmembrane protein EGFR is bound by hydrogen bonds and van der Waals forces
The research was recently published in Food Chemistry: Molecular Sciences (IF 7.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.